Skip to Content

Covalon Technologies Ltd CVALF Stock Quote

| Rating as of

PINX:CVALF

Morningstar‘s Stock Analysis CVALF

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics CVALF

Company Profile CVALF

Business Description

Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

Contact
1660 Tech Avenue, Unit 5
Mississauga, ON, L4W 5S7, Canada
T +1 905 568-8400
Industry Biotechnology
Most Recent Earnings Jun 30, 2022
Fiscal Year End Sep 30, 2022
Employees